Elie Sullivan
About Elie Sullivan
Elie Sullivan is a Senior Clinical Operations Manager at Bristol Myers Squibb, overseeing clinical research associates and managing oncology trial operations in the Northeast and Mid-Atlantic regions.
Current Role at Bristol Myers Squibb
Elie Sullivan holds the position of Senior Clinical Operations Manager at Bristol Myers Squibb, focusing on the Field, Northeast USA. In this capacity, Elie oversees a team of 15 Clinical Research Associates (CRAs) throughout the Northeast and Mid-Atlantic regions. This role involves ensuring the smooth operation of clinical trials and adherence to Good Clinical Practice (GCP) and International Council for Harmonisation (ICH) guidelines. Elie's responsibilities also include serving as the Site Relationship Lead for key oncology institutions within these regions.
Previous Experience at Organon
Before joining Bristol Myers Squibb, Elie Sullivan worked at Organon. In 2000, Elie served as a Contract Site Manager/Regulatory Manager in West Orange, New Jersey for 11 months. This role involved overseeing contract sites and ensuring regulatory compliance, gaining valuable experience that laid the groundwork for future roles in clinical operations.
Career at Eli Lilly and Company
Elie Sullivan began their career at Eli Lilly and Company, serving as a Senior Clinical Site Monitor for three years from 1997 to 2000. During this time, Elie specialized in clinical site monitoring, providing oversight and ensuring compliance with clinical trial protocols, which established a strong foundation in the field of clinical operations and monitoring.
Education Background
Elie Sullivan earned a Bachelor of Arts (BA) degree from New York University, studying Research and Experimental Psychology alongside Classic Literature from 1994 to 1997. This academic background provided Elie with a robust understanding of research methodologies and the analytical skills necessary for a career in clinical operations.
Specialization in Oncology Trials
Elie Sullivan specializes in clinical site monitoring for various oncology trials, including those for lung, melanoma, glioblastoma, gastric, and renal cancers. As the Lead Site Monitor in the lung cancer space, Elie is responsible for pre-trial site selection and oversees Site Monitor Liaisons for these programs. This specialization underscores a focused expertise in oncology, enhancing trial monitoring and site selection processes.